ICMR plans to roll out India's first indigenous dengue vaccine, DengiAll, by 2027 if clinical trials succeed. Panacea Biotec developed the single-dose vaccine, currently in Phase 3 trials with 13,000
firstpost.com
Read Full Story
Powered by U6L